NRXP insider transaction filings
NRX Pharmaceuticals, Inc. — 6 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-17. Screen NRXP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-17 | 4 | Casper Joseph Michael — Chief Operating Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | McBride Dennis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Flynn Patrick John — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Hurvitz Chaim — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-09-10 | 4 | Javitt Jonathan C — Chairman and Chief Scientist, Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ABRAMS MICHAEL S — Chief Financial Officer | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — NRX Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-07 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-07-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NRXP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →